2023. Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s147. DOI:https://doi.org/10.25251/skin.7.supp.147.